Dargantes, Bonifacio T.
HRN: 24-97-19 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/06/2024
05/13/2024
IV
Topical
BID
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes